ClinicalTrials.Veeva

Menu

Antipsychotic to Treat Psychosis Syndrome

C

Central South University

Status

Unknown

Conditions

Psychotic Disorders

Treatments

Drug: Quetiapine
Drug: olanzapine
Drug: risperidone
Drug: Aripiprazole

Study type

Interventional

Funder types

Other

Identifiers

NCT02137616
201002003 (Other Grant/Funding Number)

Details and patient eligibility

About

This study assess the safety and effects of atypical antipsychotics in subjects with psychosis syndrome and psychosis risk syndrome.

Full description

The investigators investigated whether administration of atypical antipsychotics could alleviate prodromal symptoms and be well tolerated by subjects with psychosis syndrome and psychosis risk syndrome.

Enrollment

300 estimated patients

Sex

All

Ages

16 to 30 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • were help-seeking young individuals in outpatients service
  • aged 16-30 years
  • fitted one of the following Criteria: Psychosis-risk Syndromes (COPS-SIPS) or Psychotic Syndrome (POPS-SIPS) or DSM-IV diagnosis of schizophreniform disorder

Exclusion criteria

  • a previous diagnosis of any psychotic disorder or bipolar disorders according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition;
  • symptoms fully accounted for by an Axis 1 disorder or sequelae of drug/alcohol use;
  • neurological disorders or organic disorders affecting the central nervous system, substance-related disorders or mental retardation as defined by the DSM-IV criteria;
  • history treatment of antipsychotic or antidepression, mood stabilizers or electroconvulsive therapy;
  • diagnosed as having a serious and unstable medical condition.

Trial design

Primary purpose

Prevention

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

300 participants in 4 patient groups

risperidone
Active Comparator group
Description:
low dosage of antipsychotic drug
Treatment:
Drug: risperidone
olanzapine
Active Comparator group
Description:
low doseage of antipsychotic
Treatment:
Drug: olanzapine
quetiapine
Active Comparator group
Description:
low doseage of antipsychotic
Treatment:
Drug: Quetiapine
aripiprazole
Active Comparator group
Description:
low doseage of antipsychotic
Treatment:
Drug: Aripiprazole

Trial contacts and locations

1

Loading...

Central trial contact

xiaofeng Guo, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems